We describe the case of a 70-year-old never smoker with chronic lymphocytic leukaemia, treated with single agent ibrutinib therapy. Chest imaging noted nodular change and mediastinal lymphadenopathy, which showed avid uptake on positron emission tomography and guided subsequent biopsies (bronchoscopy using endobronchial ultrasound, mediastinoscopy). Despite negative aspergillus blood immunology tests, he was found to have invasive aspergillosis, which is a known risk with ibrutinib therapy. He has since been successfully treated with antifungal therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/14782715221088973 | DOI Listing |
Publication Analysis
Top Keywords
ibrutinib therapy
12
risk ibrutinib
8
nodules nodes
4
nodes non-functioning
4
non-functioning macrophages
4
macrophages risk
4
therapy
4
therapy describe
4
describe case
4
case 70-year-old
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!